3-13571050-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001004019.2(FBLN2):āc.695T>Cā(p.Leu232Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000709 in 1,409,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004019.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLN2 | NM_001004019.2 | c.695T>C | p.Leu232Pro | missense_variant | 2/18 | ENST00000404922.8 | |
FBLN2 | NM_001165035.2 | c.695T>C | p.Leu232Pro | missense_variant | 2/18 | ||
FBLN2 | NM_001998.3 | c.695T>C | p.Leu232Pro | missense_variant | 2/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLN2 | ENST00000404922.8 | c.695T>C | p.Leu232Pro | missense_variant | 2/18 | 5 | NM_001004019.2 | P1 | |
FBLN2 | ENST00000295760.11 | c.695T>C | p.Leu232Pro | missense_variant | 2/17 | 1 | |||
FBLN2 | ENST00000492059.5 | c.695T>C | p.Leu232Pro | missense_variant | 2/18 | 2 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000121 AC: 2AN: 165668Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 88980
GnomAD4 exome AF: 7.09e-7 AC: 1AN: 1409652Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 696438
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2024 | The c.695T>C (p.L232P) alteration is located in exon 2 (coding exon 1) of the FBLN2 gene. This alteration results from a T to C substitution at nucleotide position 695, causing the leucine (L) at amino acid position 232 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at